CELLMID LIMITED
5Patents
4Active
5Granted
39Portfolio score
Filing activity: Mar 5, 2004 → Oct 14, 2015 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8128934B2 | Method for treatment or prevention of disease associated with functional disorder of regulatory T cell | Physics | 8 | Active |
| US10590192B2 | Midkine antibody | Physics | 0 | Active |
| US9624294B2 | Antibody recognizing N-domain of midkine | Chemistry; Metallurgy | 0 | Active |
| US8221758B2 | Anti-midkine antibody for preventing post-laparotomy adhesions | Chemistry; Metallurgy | 0 | Expired |
| US9023799B2 | Method to reduce loss of cardiac function following ischemia/reperfusion | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.